Your session is about to expire
← Back to Search
Ventilation
Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS (SuperNo2VA Trial)
N/A
Waitlist Available
Led By john M DeWitt, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial tests different ways to help patients with high BMI or sleep apnea breathe better during and after a medical procedure. It uses extra oxygen and a bag-mask to push air into the lungs. These methods aim to ensure patients get enough oxygen and maintain open airways.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Oxygen
Secondary study objectives
Modified Observer's Assessment and Alertness/Sedation Scale (MOAAS)
Procedural Interruptions
Total Amount of Propofol for Adequate Sedation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SuperNO2VAExperimental Treatment1 Intervention
SuperNO2VA is CPAP device to deliver oxygen with nasal mask rather than with facial mask
Group II: Facial maskActive Control1 Intervention
facial mask for oxygen delivery
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,220,053 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
9 Previous Clinical Trials
1,013 Total Patients Enrolled
john M DeWitt, MDPrincipal InvestigatorIndiana University
John M DeWitt, MDPrincipal InvestigatorIndiana University
1 Previous Clinical Trials
12 Total Patients Enrolled